Trademarkia Logo

Canada

C$
GENERATE
REGISTERED

on 13 Dec 2024

Last Applicant/ Owned by

Generate Biomedicines, Inc.

101 South Street, Suite 900Somerville MA 02143

US

Serial Number

2063290 filed on 21st May 2020

Registration Number

TMA1275564 registered on 13th Dec 2024

Registration expiry Date

21st May 2030

Correspondent Address

DEETH WILLIAMS WALL LLP

150 YORK STREET, SUITE 400TORONTO

ONTARIO

CA

M5H3S5

GENERATE

Trademark usage description

pharmaceutical preparations for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, namely virally-transmitted diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, namely virally-transmitted diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; therapeutic products for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, namely virally-transmitted diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy.


Classification kind code

11

Class [042]
Providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products.


Classification kind code

11

Mark Details


Serial Number

2063290

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 1st Mar 2022
Search Recorded
Submitted for opposition 20
on 1st Mar 2022
Examiner's First Report
Submitted for opposition 256
on 13th Sept 2021
Notification of Possible Opposition Sent
Submitted for opposition 130
on 19th May 2021
Note to file
Submitted for opposition 48
on 11th Feb 2021
Agent Changed
Submitted for opposition 257
on 12th Nov 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 11th Nov 2020
Formalized
Submitted for opposition 1
on 11th Nov 2020
Created
Submitted for opposition 228
on 21st May 2020
International Registration
Submitted for opposition 30
on 21st May 2020
Filed